Bringing the fundamentals into focus…
Back to Sutro Biopharma, Inc.
How Sutro Biopharma, Inc. stacks up
STRO · against 178 other Healthcare companies of similar size
Profitability
7/ 100
Near the bottom of its peers.
Ranked #150 of 179 · scores higher than 13% of peers
Bars: peers in each 10-point band of the profitability score34 peers with a profitability score of 0–9, including STRO · Click a bar to see the companies
Why profitability scores 7?
Weighted metrics compared with all Healthcare companies.Mainly because of its return on assets and operating margin, which are weaker than most Healthcare peers.
- a lower return on assets: weaker than 98% of peers. Return on assets: -92.8% vs peer median 1.7%
- a thinner operating margin: weaker than 91% of peers. Operating margin: -319.6% vs peer median 7.1%
- Return on invested capital is not reported, so it is left out of the score.
Metric by metric
Position: dot = STRO, ranked from the worst peer (left) to the best (right); tick = middle, shaded = middle half of peers.| Metric | STRO | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Return on invested capitalHigher is better · 142 reported | Not reported | -5.2% | — | — | 33% |
| Operating marginHigher is better · 163 reported | -319.6% | -1.9% | 20% | 33% | |
| Return on assetsHigher is better · 183 reported | -92.8% | -2.4% | 3% | 33% | |
| Return on equityHigher is better · 170 reported | Not reported | -9.8% | — | — | Context only |
| Gross marginHigher is better · 193 reported | -216.7% | 41.4% | 1% | Context only |
A metric that is not reported is left out of the score; the other weights are rescaled.
Ranking by profitability score
Top 5 and the companies ranked around STRO| Rank | Company | Market cap | Profitability | Overall |
|---|---|---|---|---|
| 1 | 261M USD | 98 | 97 | |
| 2 | 1.4B HKD (≈$181M) | 97 | 61 | |
| 2 | 356M AUD (≈$235M) | 97 | 81 | |
| 4 | 592M ILS (≈$160M) | 96 | 84 | |
| 5 | 301M USD | 95 | 67 | |
| 150 | 144.1B KRW (≈$104M) | 7 | 45 | |
| 150 | 648M HKD (≈$83M) | 7 | ||
| 150 | 271M USD | 7 | 14 | |
| 150 | 257M USD | 7 | 55 | |
| 150 | 158M USD | 7 | 14 | |
| 150 | 113M USD | 7 | 23 | |
| 156 | 1.1B HKD (≈$141M) | 6 | ||
| 156 | 110M USD | 6 | 54 | |
| 156 | 540M ILS (≈$146M) | 6 | 49 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score